Security expert Namit Verma revealed that Israel shared crucial intel with India about a threat to Rajiv Gandhi's life, but it went missing after his 1991 assassination. Verma said the political landscape changed after Gandhi's death, and the intel was misplaced or removed. Verma, an expert in global geopolitics and security, made these comments during a discussion on intelligence cooperation and security challenges. The revelation raises questions about the handling of sensitive information and its impact on national security.

In Bengaluru, India, a lookout notice was issued against JD(S) MP Prajwal Revanna by the Special Investigation Team (SIT) investigating the Hassan sex scandal. The SIT acted after Prajwal and his father failed to appear for questioning. Despite Prajwal's request for a 7-day delay, the notice was issued. Reports suggest he may be detained upon his return to the country. Prajwal, who denies all allegations, left the country after the election. Union Home Minister Amit Shah criticized the Karnataka government for allowing Prajwal to flee before concluding the Vokkaliga voting.

IndiGo, the popular low-cost airline, has announced a special reward for its hardworking employees. In May 2024, employees will receive a one-time bonus equal to 1.5 times their monthly salary. This bonus, given as an ex-gratia payment, is a token of appreciation for their outstanding performance during the fiscal year 2024. IndiGo credits its solid financial performance for this decision, highlighting a remarkable recovery since the second half of 2022. With profits soaring and ambitious growth plans, IndiGo continues to demonstrate resilience and commitment to its employees amidst the challenges of the pandemic.

Bharat Biotech emphasizes Covaxin's safety record amidst AstraZeneca's acknowledgement of rare blood clot side effects. Covaxin, developed with a focus on safety and efficacy, underwent extensive trials and monitoring, with no reported vaccine-associated incidents. The statement follows AstraZeneca's admission of potential side effects. Covaxin, the only vaccine in India's immunization program with local efficacy trials, prioritizes patient safety. Bharat Biotech underscores ongoing safety monitoring and highlights its commitment to patient safety in vaccine development. Meanwhile, AstraZeneca faces a class-action lawsuit over alleged severe injuries and deaths related to its vaccine.

In Samba district of Jammu and Kashmir, Border Security Force (BSF) personnel shot and killed a Pakistani intruder along the International Border. The incident occurred near Border Outpost Regal on Wednesday evening. Despite repeated warnings, the intruder attempted to cross into Indian territory, prompting BSF personnel to open fire around 8:20 pm. The intruder ignored the warnings and continued his attempt to sneak into India. Following the shooting, reinforcements were dispatched to the area to conduct a comprehensive search operation. The incident highlights the ongoing vigilance and security measures maintained by Indian forces along the border to prevent infiltration and maintain territorial integrity.

Following AstraZeneca's admission of Covishield's rare side-effect TTS, parents of a woman who died after receiving the vaccine plan to sue Serum Institute of India (SII). Karunya's parents will file a writ petition seeking compensation and an independent medical board to investigate her death. They criticize AstraZeneca and SII for not halting vaccine production amid early concerns. The move follows similar legal actions globally. AstraZeneca faces a UK lawsuit over vaccine side-effects. Karunya's father vows further legal action for justice, emphasizing the need to hold accountable those responsible for vaccine-related deaths.

The parents of a woman who allegedly died after taking the Covishield vaccine, developed by AstraZeneca and Oxford University, are suing Serum Institute of India. AstraZeneca admitted in court that its vaccine can cause rare side effects. The woman's father seeks compensation and an independent medical board inquiry. Despite insufficient evidence linking her death to the vaccine, legal action follows global concerns over rare blood clotting side effects. Covishield, sold worldwide, faces scrutiny amid ongoing lawsuits against AstraZeneca.

The Union health ministry has updated CoWIN vaccination certificates, removing Prime Minister Narendra Modi's photo but retaining his quote on defeating Covid-19. This change comes as concerns resurface about Covishield's possible connection to rare blood clotting issues, following AstraZeneca's admission in a UK court. The condition, known as Thrombosis with Thrombocytopenia Syndrome (TTS), has prompted closer examination of vaccination certificates in India. While Modi's name is absent from the certificates, his message remains, reflecting ongoing efforts to combat the pandemic.

The Supreme Court stressed that Hindu marriages must follow proper ceremonies to be recognized under the law. Justices urged young couples to understand the importance of marriage, warning against lavish spending and dowry demands. They said marriage builds families and strengthens communities, emphasizing its value beyond just a legal contract. The court described marriage as a lifelong commitment, essential for personal fulfillment and societal harmony. This decision aims to uphold the traditional and cultural significance of Hindu marriages, reminding everyone of its sacred role in Indian society.

Prime Minister Narendra Modi announced a change in how India deals with terrorism during a rally in Gujarat. Instead of sending diplomatic dossiers to other countries, India now takes direct action against terrorists on their own soil. Modi criticized the previous government's approach, particularly the Congress party, for its reliance on sending dossiers to Pakistan. He also emphasized the empowerment of Muslim women through the abolition of Triple Talaq, accusing Congress of using them for vote bank politics. Additionally, Modi addressed criticisms from opposition leaders, asserting his commitment to national security and governance.